Skip to main content
. 2005 Jul 20;2005(3):CD001439. doi: 10.1002/14651858.CD001439.pub2

Kizilcan 1992 C.

Methods Randomised controlled trial. Randomisation method not stated. 
 Patient blinded. Unclear blinding of surgeon and outcome assessor.
Participants 100, 66 males and 34 females enrolled in the study. 
 Age‐range: 0‐15. 
 Patients presenting parameters suggesting complicated appendicitis were not included. 
 The study has 4 subgroups (see Kizilcan 1992 A & B). 
 In Kizilcan 1992 A 50 patients enrolled in the study. 6 patients excluded after randomisation.
Interventions Treatment group: Piperacillin Na 200 mg/kg/day divided in 3 doses initiated preoperatively. 
 Placebo group: Not specified in same regime as above
Outcomes Wound infection (Not defined). 
 Postoperative intraabdominal abscess (Not defined).
Notes No drain treatment. 
 Wrote to author to specify subgrouping on drop‐outs.
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk B ‐ Unclear